Furthermore, high mobility group box 1 (HMGB1) was proven to contribute to the effect of silencing p53 on alleviating NAFLD in vitro as an autophagy regulator. This evidence concerns the gene TP53 and metabolic dysfunction-associated steatotic liver disease.